IFI6, IFI27 binds DDX58

Stable Identifier
R-HSA-9921830
Type
Reaction [binding]
Species
Homo sapiens
Related Species
Influenza A virus, Rotavirus, Hepatitis C Virus
Compartment
Synonyms
IFI6 binds RIG-I
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Interferon alpha-inducible protein 6 (IFI6) and IFI27 may regulate the intensity of innate immune responses induced after viral infections in cell cultures and in vivo (Villamayor L, López-García D et al., 2023; Villamayor L, Rivero V et al., 2023; Rivero V et al., 2024). The molecular mechanism likely involves the interaction of IFI6 or IFI27 with dsRNAs and pattern recognition receptors such as DDX58 (RIG-I) and IFIH1 (MDA5), impairing the receptor activation by viral RNA (Villamayor L, López-García D et al., 2023; Villamayor L, Rivero V et al., 2023). In addition, some studies suggest that IFI6 and IFI27 modulate cellular responses, such as programmed cell death, to influence the balance between immune response and cellular damage caused by microbial infection or by health conditions associated with cancer (Gytz H et al., 2017; Wang H et al., 2018).

This Reactome event shows interaction between the outer mitochondrial membrane (OMM)-bound IFI6, IFI27 and cytosolic DDX58 (RIG-I) in the presence of viral RNA. However, IFI6 is primarily localized in the inner mitochondrial membrane (Cheriyath V et al., 2018; Liu Z et al., 2020). Further clarifications are needed for this interaction.

Literature References
PubMed ID Title Journal Year
37187533 The IFN-stimulated gene IFI27 counteracts innate immune responses after viral infections by interfering with RIG-I signaling

Martínez-Sobrido, L, Rivero, V, DeDiego, ML, López-García, D, Villamayor, L, Nogales, A

Front Microbiol 2023
36793726 Interferon alpha inducible protein 6 is a negative regulator of innate immune responses by modulating RIG-I activation

Martínez-Sobrido, L, Rivero, V, DeDiego, ML, López-García, D, Villamayor, L, Topham, DJ, Nogales, A

Front Immunol 2023
Participants
Participates
Authored
Reviewed
Created
Cite Us!